Food research international (Ottawa, Ont.)
Cure8 research brief
Why This Matters
This preclinical study identifies a plant-derived polysaccharide that reduced inflammation and improved gut barrier function in a mouse model of colitis and points to microbiome changes and an S100A8/A9–NF‑κB pathway as mechanisms—potentially relevant for future therapies research.
Who Should Pay Attention
Researchers studying IBD mechanisms or therapeutic discovery, clinicians following translational IBD research, and patients interested in laboratory-stage developments in ulcerative colitis.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is an abstract‑level report of preclinical research in mice (plus cellular experiments). The authors gave PLPN-2 at three doses and measured disease activity index, myeloperoxidase, gut microbiota changes by 16S sequencing, cytokine pathway activity, and proteomics that implicated S100A8/A9.
In vitro work in THP-1 cells showed PLPN-2 reduced S100A8/A9 secretion and NF-κB activation, and overexpressing S100A8/A9 counteracted PLPN-2’s effects.
This study suggests a candidate natural polysaccharide may modulate dysbiosis and an S100A8/A9–NF‑κB inflammatory axis in experimental colitis, but it is preclinical and does not establish safety or efficacy in people.
Keep In Mind
Results are from animal and cell experiments reported in an abstract/full-text summary; they do not reflect tested treatments in humans. Further preclinical validation and clinical trials would be required before any clinical use.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFood research international (Ottawa, Ont.)
AuthorsLi PP, Zhao HS, Jiang XM +6 more
Study typeIm, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 7, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Gut commensal Lachnospira eligens alleviates ulcerative colitis by mediating isodeoxycholic acid via the STAT3/NF-κB signaling pathway
The study identifies a specific gut microbe and a bile-acid metabolite that reduced inflammation in a mouse colitis model and implicates STAT3/NF-κB pathways — a potential new avenue for microbiome-based therapeutics for...
Gut Microbiota-Dependent Tryptophan Metabolism Drives the Therapeutic Effects of Baitouweng Tang in Colitis via the AhR Pathway.
This preclinical work suggests the gut microbiota and tryptophan-derived metabolites that activate AhR may be important in reducing colitis-related inflammation — a potential route for future therapies relevant to...
Prunella vulgaris Polysaccharide Ameliorates DSS-Induced Ulcerative Colitis by Increasing the Abundance of Ligilactobacillus agilis to Inhibit Inflammation and Preserve Intestinal Barrier Integrity
A plant polysaccharide (PVP) reduced inflammation and preserved intestinal barrier proteins in a mouse model of ulcerative colitis, apparently by increasing a specific gut bacterium. This points to a microbiome-related...